Literature DB >> 18067763

Interventricular septum motion abnormalities: unexpected echocardiographic changes of Brugada syndrome.

Zheng-rong Huang1, Liang-long Chen, Wei-hua Li, Qi-zhu Tang, Cong-xin Huang, Qiang Xie, Gang Wu, Lin Fan.   

Abstract

BACKGROUND: There remains controversy about whether Brugada syndrome (BS) has structural heart changes. We occasionally noted that a patient with BS had a quite unusual regional wall motion abnormality at the basal segment of the interventricular septum (IVS) during echocardiographic examination. The unexpected finding promoted us to reexamine our patients with BS by echocardiographic interrogation in the present study.
METHODS: Patients with BS (n = 11), patients with complete right bundle branch block (RBBB) (n = 11), and control subjects (n = 11) were enrolled in this study. Two-dimensional echocardiography (2DE) was performed to obtain parasternal left ventricular long axis view on which M-mode scanning line was adjusted to be perpendicular to the basal segment of IVS for delineation of the segmental motion curve, with a simultaneously electrocardiographic tracing.
RESULTS: 2DE revealed a rapid swing motion shifting toward the right ventricle of the IVS basal segment at early systole in 73% (8/11) patients with BS, which was further confirmed on the M-mode curve evidenced by an early systolic notch toward the right ventricle. The position of the notch corresponded to C-point on the mitral motion curve, lasting for (53 +/- 5) ms. There were no similar changes both in patients with RBBB and in the control subjects.
CONCLUSION: IVS basal motion abnormalities at early-systolic phase may be the novel finding of BS.

Entities:  

Mesh:

Year:  2007        PMID: 18067763

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  1 in total

1.  Electrophysiological characteristics of a SCN5A voltage sensors mutation R1629Q associated with Brugada syndrome.

Authors:  Zhipeng Zeng; Jieqiong Zhou; Yuxi Hou; Xiaojing Liang; Ziguan Zhang; Xuejing Xu; Qiang Xie; Weihua Li; Zhengrong Huang
Journal:  PLoS One       Date:  2013-10-22       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.